Bevacizumab in adjuvant treatment of non-small-cell lung cancer.

Lancet Oncol

Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, NC 27514, USA. Electronic address:

Published: December 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30843-4DOI Listing

Publication Analysis

Top Keywords

bevacizumab adjuvant
4
adjuvant treatment
4
treatment non-small-cell
4
non-small-cell lung
4
lung cancer
4
bevacizumab
1
treatment
1
non-small-cell
1
lung
1
cancer
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!